DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Vitiligo - Epidemiology Forecast to 2032
US$ 3,950.00
... epidemiology historical and forecasted data of Vitiligo prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease ... global Vitiligo market. Identifying prevalent patient populations as well as risk factors in the global Vitiligo market ...
January 2022
60 pages
Vitiligo - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... in Vitiligo Vitiligo Pipeline Analysis Vitiligo Market Size and Trends Vitiligo Market Opportunities Impact of upcoming Therapies in Vitiligo Vitiligo Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Vitiligo Report ...
January 2022
200 pages
Vivacor - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Vivacor API intelligence over Vivacor and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Vivanza - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Vivanza API intelligence over Vivanza and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Volibris - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Volibris API intelligence over Volibris and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Votrient - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Votrient API intelligence over Votrient and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Votubia - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Votubia API intelligence over Votubia and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Vyvanse - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Vyvanse API intelligence over Vyvanse and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xanax - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xanax API intelligence over Xanax and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xarelto - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xarelto API intelligence over Xarelto and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xelevia - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xelevia API intelligence over Xelevia and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xeloda - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xeloda API intelligence over Xeloda and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xenazine - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xenazine API intelligence over Xenazine and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xeristar - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xeristar API intelligence over Xeristar and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xeroquel LP - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xeroquel LP API intelligence over Xeroquel LP and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xopenex - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xopenex API intelligence over Xopenex and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xtandi - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xtandi API intelligence over Xtandi and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xyrem - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xyrem API intelligence over Xyrem and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xyzall - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xyzall API intelligence over Xyzall and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zactos - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zactos API intelligence over Zactos and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zaldiar - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zaldiar API intelligence over Zaldiar and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zeclar - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zeclar API intelligence over Zeclar and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zeffix - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zeffix API intelligence over Zeffix and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zelboraf - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zelboraf API intelligence over Zelboraf and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zelitrex - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zelitrex API intelligence over Zelitrex and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zemplar - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zemplar API intelligence over Zemplar and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zenhale - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zenhale API intelligence over Zenhale and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zienam - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zienam API intelligence over Zienam and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zient - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zient API intelligence over Zient and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zintrepid - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zintrepid API intelligence over Zintrepid and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zispin - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zispin API intelligence over Zispin and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zocor - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zocor API intelligence over Zocor and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zoloft - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zoloft API intelligence over Zoloft and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zoltec - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zoltec API intelligence over Zoltec and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zometa Concentrate - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zometa Concentrate API intelligence over Zometa Concentrate and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zortress - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zortress API intelligence over Zortress and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zosyn - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zosyn API intelligence over Zosyn and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zurcal - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zurcal API intelligence over Zurcal and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zyprexa - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zyprexa API intelligence over Zyprexa and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zytiga - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zytiga API intelligence over Zytiga and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Aciphex - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Aciphex API intelligence over Aciphex and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Acromegaly - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Acromegaly Key assessments Patient Segmentation in Acromegaly Acromegaly Risk & Burden Factors driving growth in a specific Acromegaly patient population
January 2022
60 pages
Acthar Gel - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Acthar Gel API intelligence over Acthar Gel and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Actinic Keratosis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Actinic Keratosis Key assessments Patient Segmentation in Actinic Keratosis Actinic Keratosis Risk & Burden Factors driving growth in a specific Actinic Keratosis patient population
January 2022
60 pages
Acute Coronary Syndrome - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Acute Coronary Syndrome Key assessments Patient Segmentation in Acute Coronary Syndrome Acute Coronary Syndrome Risk & Burden Factors driving growth in a specific Acute Coronary Syndrome patient population
January 2022
60 pages
Acute Coronary Syndrome - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Acute Coronary Syndrome Report Assessment Current Treatment Practices in Acute Coronary Syndrome Unmet Needs in Acute Coronary Syndrome Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...
January 2022
200 pages
Acute Renal Failure (ARF) (Acute Kidney Injury) - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Acute Renal Failure (ARF) (Acute Kidney Injury) Key assessments Patient Segmentation in Acute Renal Failure (ARF) (Acute Kidney Injury) Acute Renal Failure (ARF) (Acute Kidney Injury) Risk & Burden Factors driving growth ...
January 2022
60 pages
Acute Respiratory Distress Syndrome - Epidemiology Forecast to 2032
US$ 3,950.00
... strengths 10 Year Forecast 7MM Coverage Total Cases in Acute Respiratory Distress Syndrome Key assessments Patient Segmentation in Acute Respiratory Distress Syndrome Acute Respiratory Distress Syndrome Risk & Burden Factors driving growth in a specific Acute Respiratory Distress Syndrome patient population
January 2022
60 pages
